Source: BioPortfolio

BatuBiologics: Batu Biologics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250

SummaryBatu Biologics Inc Batu Biologics is a biotechnology based pharmaceutical company which develops and commercializes novel cell and gene therapies. Its lead product ValloVax a cellular antiangiogenic cancer vaccine is developed to induce an immune re...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Thomas Ichim's photo - President & CEO of Batu Biologics

President & CEO

Thomas Ichim

CEO Approval Rating

90/100

Read more